Applied StemCell
appliedstemcell.com
Actively hiring
Synthetic Biology
Cell & Gene Therapy
Biotechnology
As featured in
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Total raised
$19M
1 round on record
Latest round
$19M
Venture round · May 2016 · 10 yr ago
Team
36
US Form 5500 (plan participants) · Dec 2025 · +20% in a year
Backers
1
First Analysis
The money's age
Long since its last round
124 months since the last round · not hiring
Momentum
15/100
in the news
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Jul 8
Partnership RoosterBio and Applied StemCell Partner to Advance Scalable iPSC-Based Bioprocess Solutions · morningstar.com
Jun 23
Partnership Applied StemCell and Syntax Bio collaborate to advance next-generation regenerative medicine · appliedstemcell.com
Mar 24
Partnership Applied StemCell and Cellipont Bioservices partner to offer a seamless path for iPSC-derived cell therapy development · appliedstemcell.com
Aug 21, 2025
New executive Applied StemCell Appoints Dolores Baksh, Ph.D., as Chief Executive Officer · appliedstemcell.com
Oct 10, 2023
Acquired QHP Capital buys Applied StemCell · PE Hub
Jun 13, 2023
Partnership Applied StemCell Inc. Partners with CIRM to Provide Clinical-Grade iPSCs and Access to Its Proprietary Gene Editing Technologies to Accelerate the De… · businesswire.com
May 18, 2016
Raised a round Venture round $19M · SEC Form D
2008
Founded
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | May 2016 | $19M | — | SEC Form D |
Registers and programsofficial lists and records that name the company
| Legal entity | APPLIED STEMCELL INC | SEC Form D |
Founders and leadersfrom filings, registers and the company's site
Ruhong JiangExecutive Officer, DirectorSEC Form D
Backed byfrom the funds' portfolios and accelerator catalogs
First Analysis Similar startupsby what they do, their industry and backers
EditCo provides CRISPR gene editing services, CRISPR products & genome engineering solutions for disease models, drug discovery and cell…
Logomix is a Japan-based synthetic biology company that develops genome engineering technologies for human cells. Its Geno-Writing platform…
Kytopen is accelerating access to the next generation of cell therapies through scalable genome engineering by solving manufacturing…
At Ncardia, we are pioneers in iPSC technology providing high-quality cells, relevant screening assays and robust iPSC differentiation…
Form Bio accelerates genetic medicine with AI—optimizing AAV vectors, enhancing CRISPR accuracy, boosting yields up to 4.4x, and improving…
Co-founded in 2017 by two pioneers in genome editing technology, Qihan Biotech has world-leading capabilities in multiplexable genome…
News
Applied StemCell & RoosterBio enter strategic partnership to develop and commercialize scalable iPSC-based bioprocess solutions
Applied StemCell & RoosterBio enter strategic partnership to develop and commercialize scalable iPSC-based bioprocess solutions
Read more
Report
Applied StemCell and RoosterBio collaborate to advance scalable iPSC-based bioprocessing
Applied StemCell and RoosterBio collaborate to advance scalable iPSC-based bioprocessing Applied StemCell (ASC) is excited to announce a strategic partnership with RoosterBio focused on developing and commercializing scalable iPSC-based bioprocess solutio
Read more
Report
RoosterBio and Applied StemCell Partner to Advance Scalable iPSC-Based Bioprocess Solutions
Read more
Report
Applied StemCell and Syntax Bio collaborate to advance next-generation regenerative medicine
Applied StemCell and Syntax Bio collaborate to advance next-generation regenerative medicine Applied StemCell (ASC) is excited to announce a strategic collaboration with Syntax Bio focused on advancing stem cell research and accelerating the development o
Read more
Report
Pro access
Upgrade to see all 19 mentions
Upgrade to a paid plan to read every media mention of this company - funding news, awards, product launches and press releases from all the outlets writing about it.
Every media mention and press release
Funding news, awards and product launches
Fresh coverage from every outlet writing about the company
Upgrade now
Cancel anytime. Secure checkout. Instant activation.
People
Ruhong Jiang
Executive Officer, Director
Zhenyu Xiao
Director
Guoliang Yu
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Milpitas
United States
HQ
Address:
50-200 est. staff
521 Cottonwood Dr, Suite #111 Milpitas, California 95035, USA
Financials
Total raised
$19M
Latest round
Venture - Series Unknown
Funding rounds
1
Funding rounds
| Round | Announced | Amount | |
|---|---|---|---|
| Venture - Series Unknown | 2016 | $19M | Details |